[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Does BMC's business model conflict with Editorial Independence?
- To: <liblicense-l@lists.yale.edu>
- Subject: RE: Does BMC's business model conflict with Editorial Independence?
- From: "Peter Banks" <pbanks@diabetes.org>
- Date: Sun, 14 May 2006 18:24:04 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
I think Phil is correct--the editorial inducements of page charges are not the same as those of author's fees. Our editors are paid a contracted amount for managing peer review operations. That doesn't go up with the number of submissions, so the editor has no financial motivation to accept more papers. Indeed, contrary to the absurd proposition that we encouarge editors to increase their acceptance rate so that we can make more profit, in recent past we have actually done the opposite--in the face of soaring submission rates, we required them to REDUCE the acceptance rate both so costs and subscription prices could be controlled and quality could be maintained. For example, these are the acceptance rates for Diabetes Care for the past three years 2003 30.3% 2004 29.6% 2005 20.4% To Phil's concern about the ethics of editors being compensated from processing charges, I will add another one: In clinical medicine, a lot of the funding for drug studies comes from pharmaceutical companies. Almost any senior researcher worth having as an editor will have relationships with one or more drug companies (whether consulting, speaking, or grant support). The granter-pays model now creates a situation in which the editor has a difficult dual interest--both a financial relationship with the pharma firm and potential recipient of a portion of manuscript fees paid by that firm. Of course, editors of traditional journal also have relationships with firms, but the money the editorial honoraria they receive from the publisher has no direct connection to the firm and the decision to accept or reject a manuscript has no personal financial aspect. I think the OA model for clinical medical journals is going to require a great deal more thought about how to isolate the editor from pressure by pharmaceutical firms. Anyone who doesn't think that pharmaceutical brand managers aren't salivating over the chance to pay for manuscripts (chump change for these companies), with its attendant potential to influence content, hasn't met many brand managers. Peter Banks Publisher Starting June 1, my contact information is: Peter Banks Banks Publishing 10332 Main Street Box 158 Fairfax, VA 22030 Phone (703) 591-6544 Fax (703) 383-0765 pbanks@bankspub.com >>> pmd8@cornell.edu 05/11/06 8:05 PM >>> Matt Cockerill wrote: "The suggestion that open access journal editors are conflicted because their journal's revenue depends on article processing charges is really just the same old suggestion that open access journals in general are conflicted by article processing charges. But as has been widely pointed out, if that is a conflict of interest, then all journals with page charges have that same conflict of interest. And since traditional publishers justify subscription price increases based on the increasing page count of their journals, traditional publishers too face the very same potential conflict of interest." Response: I fail to see this as a strong argument by similarity. Page charges would have the same corruptive effect on editorial independence only if editors received a "share of the revenue" (Matt's words) for each check that was sent in by authors. The reward system for BMC editors is essentially that of any commission salesman. Accept more articles, get richer. Their business model is that simple. I am also told by a BMC editor that they are economic consequences for waiving article processing fees. Not only do editors forfeit their commission, but they are required to pay for these pro bono articles out of their own coffers. Both of these BMC business practices seem to contradict ethical policies set up to separate the business interests of the publisher and editorial independence. As I quoted yesterday from the World Association of Medical Editors, "Editors-in-chief should establish procedures that guard against the influence of commercial and personal self-interest on editorial decisions." [3] Moreover, I do not see a strong and direct argument between page counts, editorial remuneration, and justification for higher subscription prices. I wouldn't disagree that some editors of large journals receive more compensation than editors of smaller journals, yet I don't see the direct and immediate link between editorial compensation and subscription prices. A police officer may receive a raise at the end of the year for doing good work, but the officer that receives a direct cut from every ticket he issues has a direct conflict of interest between his financial well-being and his obligation to be a fair and honest arbitrator of the law. In the same way, the editorial remuneration practices of BMC do not give me assurances that BMC editors are fair and honest arbitrators of their editorial responsibilities. --Phil Davis
- Prev by Date: Re: Does BMC's business model conflict with Editorial Independence?
- Next by Date: Re: Peter and Jan, re: NYT on Cornyn-Lieberman
- Previous by thread: PayPal - Check your account
- Next by thread: RE: Does BMC's business model conflict with Editorial Independence?
- Index(es):